(297 days)
No
The summary describes a physical dental implant system and its components, with no mention of software, algorithms, or data processing that would indicate the use of AI/ML.
Yes
The device is intended to restore aesthetics and chewing function by providing support for prosthetic devices (artificial teeth), which is considered a therapeutic purpose.
No
The device is an implant system designed to provide support for prosthetic devices, not to diagnose a condition.
No
The device description clearly outlines physical components such as implants, abutments, and surgical tools made from materials like zirconia and PEEK, indicating it is a hardware-based medical device.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device is "surgically placed in the bone of the upper and lower jaw to provide support for prosthetic devices... in order to restore aesthetics and chewing function." This describes a surgical implant, not a device used to examine specimens derived from the human body for the purpose of providing information for diagnosis, monitoring, or compatibility testing.
- Device Description: The description details the physical components of the dental implant system (implants, abutments, screws, healing caps, etc.) and how they are used in a surgical procedure. There is no mention of reagents, calibrators, controls, or any other components typically associated with IVD devices.
- Lack of IVD Characteristics: The text does not mention any of the key characteristics of an IVD, such as:
- Analyzing biological samples (blood, urine, tissue, etc.)
- Providing diagnostic information
- Using laboratory techniques
- Measuring analytes
The device is a surgically implanted medical device designed to restore function and aesthetics.
N/A
Intended Use / Indications for Use
The ZERAMEX® XT Dental Implant System is intended to be surgically placed in the bone of the upper and lower jaw to provide support for prosthetic devices, such as artificial teeth, in order to restore aesthetics and chewing function. The ZERAMEX® XT Dental Implant System can be used for single or multiple unit restorations. The ZERAMEX® XT Dental Implants are indicated for delayed loading. The ZERAMEX® dental implants are specially indicated for patients with metal allergies/intolerances and chronic illnesses due to metal allergies/ intolerances.
The NobelPearl Dental Implant System is intended to be surgically placed in the bone of the upper and lower jaw to provide support for prosthetic devices, such as artificial teeth, in order to restore aesthetics and chewing function. The NobelPearl Dental Implant System can be used for single or multiple unit restorations.
NobelPearl Dental Implant System are intended for delayed loading.
NobelPearl Dental Implant System are specially indicated for patients with metal allergies/intolerances and chronic illness due to metal allergies/intolerances.
Product codes (comma separated list FDA assigned to the subject device)
DZE, NHA
Device Description
The Zeramex® XT Dental Implant System is an endosseous dental implant/abutment system including various sizes of endosseous two piece dental implants, abutments, and accessories. The Zeramex® XT implants may be restored with screw retained Zeramex® XT abutments. The Zeramex® XT implants are placed using the Zeramex® XT surgical tools.
The NobelPearl Dental Implant System is an endosseous dental implant/abutment system including various sizes of endosseous two piece dental implants, abutments, and accessories. The NobelPearl Dental Implant System may be restored with screw retained NobelPearl abutments. The NobelPearl Dental Implant System are placed using the NobelPearl surgical tools.
The implants, abutments, and surgical tools for the Zeramex® XT and NobelPearl Dental Implant Systems are exactly the same; two trade names are being used for marketing purposes.
The implants, produced from aluminum toughened zirconia (conforming to ISO 6474-1:2010 Implants for Surgery - Ceramic Materials and ISO 6872:2015 Dentistry - Ceramic Materials), are provided sterile in two (2) diameters (Ø 4.2 mm (RB), and 5.5 mm (WB)) and three (3) lengths (8 mm, 10 mm, and 12 mm). The Ø 4.2 mm implant is also provided in 14 mm. The implants are designed with a "bolt-in tube" internal connection which provide anti-rotational features.
Straight and angular (15°) screw retained abutments, provided non-sterile in two sizes (RB; Ø 5.0 mm and SB, Ø 6.0 mm), are compatible for use with the system implants. The straight and angular abutments are made from the same zirconium materials as the system implants.
The screw retained abutments fit within four (4) retention elements and are affixed to the implant with a carbon fiber reinforced PEEK-Optima™ Ultra VICARBO® screw (straight) which fits the internal thread of the implant and provides a secure, screw retained ceramic on ceramic connection.
Healing caps and gingivaformers are also provided in the system. These components, provided in two sizes, are manufactured from PEEK and are connected to the implant using a screw. Provisional restoration components may be used to support temporary crowns after the healing period. The provisional restorations and the provisional restoration screws are made of carbon fiber reinforced PEEK.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
bone of the upper and lower jaw
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Fatigue testing in accordance with ISO 14801 Second Edition 2007-11-15 Dentistry-Implants-Dynamic Fatigue Test for Endosseous Dental Implants was conducted on the subject devices, Zeramex® XT and NobelPearl Dental Implant Systems. The fatigue testing as conducted in saline because of the ceramic/polymer device composition.
The following performance tests, conducted on the predicate devices, are being leveraged in support of this submission:
- shelf-life, packaging, and transport validation studies:
- cleaning and sterilization validation;
- ISO 17665-1 First Edition 2006-08-15 Sterilization of Health Care Products -Moist Heat - Part 1: Requirements For The Development, Validation And Routine Control Of A Sterilization Process For Medical Devices;
- ISO/TS 17665-2:2009-01-15 Sterilization Of Health Care Products Moist Heat o - Part 2: Guidance On The Application Of ISO 17665-1;
- ISO 11737-1 Second Edition 2006-04-01 Sterilization Of Medical Devices - O Microbiological Methods - Part 1: Determination Of A Population Of Microorganisms On Products [Including: Technical Corrigendum 1 (2007)]; and
- ISO 11737-2 Second Edition 2009-11-15 Sterilization Of Medical Devices o Microbiological Methods - Part 2: Tests Of Sterility Performed In The Definition, Validation and Maintenance Of A Sterilization Process.
- biocompatibility;
- ISO 6474-1 First Edition 2010-02-15 Implants for Surgery Ceramic Materials o Part 1: Ceramic Materials Based on High Purity Alumina, and
- o ISO 6872 Fourth Edition 2015-06-01 Dentistry Ceramic Materials.
- bacterial endotoxin testing (LAL Method);
- analysis of surface composition; and
- surface roughness and contact angle testing.
Clinical Studies:
Data supporting the Zeramex® T Dental Implant System and Zeramex® P6 Dental Implant System are applicable to the subject devices as the products are made from the same materials, undergo the same surface treatments, and have the same outer design. Fatigue testing supports that the subject devices can withstand clinically relevant forces.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 872.3630 Endosseous dental implant abutment.
(a)
Identification. An endosseous dental implant abutment is a premanufactured prosthetic component directly connected to the endosseous dental implant and is intended for use as an aid in prosthetic rehabilitation.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left, there is a circular seal with an eagle emblem and text that reads "DEPARTMENT OF HEALTH & HUMAN SERVICES-USA." To the right, there is a blue square with the letters "FDA" in white. Next to the square, the text "U.S. FOOD & DRUG ADMINISTRATION" is written in blue.
November 16, 2018
Dentalpoint AG % Elizabeth Rose Manager, Medical Devices Mapi USA, Inc. 2343 Alexandria Drive Suite 100 Lexington, Kentucky 40504
Re: K180184
Trade/Device Name: Zeramex® XT Dental Implant System, NobelPearl Dental Implant System Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: Class II Product Code: DZE, NHA Dated: October 18, 2018 Received: October 19, 2018
Dear Elizabeth Rose:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm_identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.html; good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Andrew I. Steen -S
for Tina Kiang, Ph.D. Acting Director Division of Anesthesiology. General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K180184
Device Name Zeramex® XT Dental Implant System
Indications for Use (Describe)
The ZERAMEX® XT Dental Implant System is intended to be surgically placed in the bone of the upper and lower jaw to provide support for prosthetic devices, such as artificial teeth, in order to restore aesthetics and chewing function. The ZERAMEX® XT Dental Implant System can be used for single or multiple unit restorations. The ZERAMEX® XT Dental Implants are indicated for delayed loading. The ZERAMEX® XT dental implants are specially indicated for patients with metal allergies/intolerances and chronic illnesses due to metal allergies/ intolerances.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CER 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Indications for Use
510(k) Number (if known) K180184
Device Name
NobelPearl Dental Implant System
Indications for Use (Describe)
The NobelPearl Dental Implant System is intended to be surgically placed in the bone of the upper and lower jaw to provide support for prosthetic devices, such as artificial teeth, in order to restore aesthetics and chewing function. The NobelPearl Dental Implant System can be used for single or multiple unit restorations.
NobelPearl Dental Implant System are intended for delayed loading.
NobelPearl Dental Implant System are specially indicated for patients with metal allergies/intolerances and chronic illness due to metal allergies/intolerances.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ☒ Prescription Use (Part 21 CFR 801 Subpart D) | ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
3.0 510(k) Summary
I. Submitter
Dentalpoint AG Bodenäckerstrasse 5 Spreitenbach, 8957 Switzerland
Phone: (+41) 44 542 41 71 Fax: (+41) 44 388 36 39
Contact Person: Anja Lieberherr, Quality Management Date Prepared: November 16, 2018
II. Device
| Device Proprietary Name: | Zeramex® XT Dental Implant System and NobelPearl Dental
Implant System |
|--------------------------|---------------------------------------------------------------------------|
| Common or Usual Name: | Dental Implant System |
| Classification Name: | Endosseous Dental Implant |
| Regulation Number: | 21 CFR 872.3640 |
| Primary Product Code: | DZE |
| Secondary Product Code | NHA |
| Device Classification | II |
III. Predicate Device
Substantial equivalence is claimed to the following primary predicate devices:
-
Zeramex® T Dental Implant System, K133255, Dentalpoint AG
The following devices are referenced within the submission: -
Zeramex® P6 Dental Implant System, K163043, Dentalpoint AG
-
Zeramex® P6 Dental Implant System, K152385, Dentalpoint AG
IV. Device Description
The Zeramex® XT Dental Implant System is an endosseous dental implant/abutment system including various sizes of endosseous two piece dental implants, abutments, and accessories. The Zeramex® XT implants may be restored with screw retained Zeramex® XT abutments. The Zeramex® XT implants are placed using the Zeramex® XT surgical tools.
5
The NobelPearl Dental Implant System is an endosseous dental implant/abutment system including various sizes of endosseous two piece dental implants, abutments, and accessories. The NobelPearl Dental Implant System may be restored with screw retained NobelPearl abutments. The NobelPearl Dental Implant System are placed using the NobelPearl surgical tools.
The implants, abutments, and surgical tools for the Zeramex® XT and NobelPearl Dental Implant Systems are exactly the same; two trade names are being used for marketing purposes.
The implants, produced from aluminum toughened zirconia (conforming to ISO 6474-1:2010 Implants for Surgery - Ceramic Materials and ISO 6872:2015 Dentistry - Ceramic Materials), are provided sterile in two (2) diameters (0 4.2 mm (RB), and 5.5 mm (WB)) and three (3) lengths (8 mm, 10 mm, and 12 mm). The Ø 4.2 mm implant is also provided in 14 mm. The implants are designed with a "bolt-in tube" internal connection which provide anti-rotational features.
Straight and angular (15°) screw retained abutments, provided non-sterile in two sizes (RB; Ø 5.0 mm and SB, Ø 6.0 mm), are compatible for use with the system implants. The straight and angular abutments are made from the same zirconium materials as the system implants.
The screw retained abutments fit within four (4) retention elements and are affixed to the implant with a carbon fiber reinforced PEEK-Optima™ Ultra VICARBO® screw (straight) which fits the internal thread of the implant and provides a secure, screw retained ceramic on ceramic connection.
Healing caps and gingivaformers are also provided in the system. These components, provided in two sizes, are manufactured from PEEK and are connected to the implant using a screw. Provisional restoration components may be used to support temporary crowns after the healing period. The provisional restorations and the provisional restoration screws are made of carbon fiber reinforced PEEK.
V. Indications for Use
Zeramex® XT Dental Implant System
The ZERAMEX® Dental Implant System is intended to be surgically placed in the bone of the upper and lower jaw to provide support for prosthetic devices, such as artificial teeth, in order to restore aesthetics and chewing function. The ZERAMEX® Dental Implant System can be used for single or multiple unit restorations. The ZERAMEX® Dental Implants are indicated for delayed loading. The ZERAMEX® dental implants are specially indicated for patients with metal allergies/intolerances and chronic illnesses due to metal allergies/intolerances.
NobelPearl Dental Implant System
6
The NobelPearl Dental Implant System is intended to be surgically placed in the bone of the upper and lower jaw to provide support for prosthetic devices, such as artificial teeth, in order to restore aesthetics and chewing function. The NobelPearl Dental Implant System can be used for single or multiple unit restorations. NobelPearl Dental Implant System are intended for delayed loading. NobelPearl Dental Implant System are specially indicated for patients with metal allergies/intolerances and chronic illness due to metal allergies/intolerances.
VI. Comparison of Technological Characteristics
The Zeramex® XT and NobelPearl Dental Implant Systems and the predicate devices share the following characteristics:
- two-piece design (K133255 and K163043); ●
- implant and abutment material of construction (K163043);
- screw material of construction (K133255 and K163043);
- implant lengths (K133255 and K163043);
- implant diameters (K133255);
- abutment angulation (K133255 and K163043);
- screw retained implant/abutment connection (K163043);
- provision of carbon-fiber reinforced PEEK screws (K163043); and
- implant and abutment sterilization methods. ●
The Zeramex® XT and NobelPearl Dental Implant Systems are technologically different from the predicate devices with respect to the anti-rotational feature. The subject devices feature a "Bolt-In Tube" connection with four (4) retention elements, while the predicate devices have internal cylindrical connections. The Zeramex® P6 Dental Implant System also has an external hexagonal anti-rotational feature.
| | Zeramex® XT and NobelPearl
Dental Implant Systems | Zeramex® T Dental Implant
System (K133255) | Zeramex® P6 Dental Implant
System (K163043) |
|------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Manufacturer | Dentalpoint AG | Dentalpoint AG | Dentalpoint AG |
| Indications for
Use | The ZERAMEX® Dental
Implant System is intended to
be surgically placed in the bone
of the upper and lower jaw to
provide support for prosthetic
devices, such as artificial teeth,
in order to restore aesthetics
and chewing function. The
ZERAMEX® Dental Implant
System can be used for single
or multiple unit restorations. | The Zeramex® T Dental
Implant System is intended to
be surgically placed in the bone
of the upper and lower jaw to
provide support for prosthetic
devices, such as artificial teeth,
in order to restore chewing
function.
The Zeramex® T Dental
Implant System can be used for | The Zeramex® P6 Dental
Implant System is intended to
be surgically placed in the bone
of the upper and lower jaw to
provide support for prosthetic
devices, such as artificial teeth,
in order to restore chewing
function.
The Zeramex® P6 Dental
Implant System can be used for |
7
| The ZERAMEX® Dental
Implants are indicated for
delayed loading. The
ZERAMEX® dental implants
are specially indicated for
patients with metal
allergies/intolerances and
chronic illnesses due to metal
allergies/intolerances.
The NobelPearl Dental Implant
System is intended to be
surgically placed in the bone of
the upper and lower jaw to
provide support for prosthetic
devices, such as artificial teeth,
in order to restore aesthetics
and chewing function. The
NobelPearl Dental Implant
System can be used for single
or multiple unit restorations.
NobelPearl Dental Implant
System are intended for delayed
loading. NobelPearl Dental
Implant System are specially
indicated for patients with
metal allergies/intolerances and
chronic illness due to metal
allergies/intolerances. | single or multiple unit
restorations.
Zeramex® T implants are
intended for delayed loading.
The Zeramex® T dental
implants are specially indicated
for patients with metal allergies
and chronic illnesses due to
metal allergies.
The Zeramex® T (Ø 3.5 mm)
implant may only be used in the
anterior teeth in the lower jaw
and lateral teeth in the upper
jaw. | single or multiple unit
restorations.
The Zeramex® P6 implants are
intended for delayed loading.
The Zeramex® P6 implants are
specially indicated for patients
with metal allergies/
intolerances and chronic illness
due to metal
allergies/intolerances.
The Zeramex® P6 (Ø3.3mm
SN) implant may only be used
in the anterior teeth in the lower
jaw and lateral incisor in the
upper jaw. |
| ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
|---|
Discussion
The technological difference between the subject and predicate devices does not raise new questions. As seen above, the Zeramex® XT and NobelPearl Dental Implant Systems have the same indications for use, materials of construction, design, size, surface treatment, and sterilization methods as the predicate devices. The data within this submission support that the subject devices are substantially equivalent to the identified predicate devices.
VII. Performance Data
As the subject devices are a line extension to the Zeramex® Implant Systems, verification activities, as identified through risk analysis, were conducted to written protocols with predefined acceptance criteria.
8
Fatigue testing in accordance with ISO 14801 Second Edition 2007-11-15 Dentistry-Implants-Dynamic Fatigue Test for Endosseous Dental Implants was conducted on the subject devices, Zeramex® XT and NobelPearl Dental Implant Systems. The fatigue testing as conducted in saline because of the ceramic/polymer device composition.
The following performance tests, conducted on the predicate devices, are being leveraged in support of this submission:
- shelf-life, packaging, and transport validation studies:
- cleaning and sterilization validation; ●
- o ISO 17665-1 First Edition 2006-08-15 Sterilization of Health Care Products -Moist Heat - Part 1: Requirements For The Development, Validation And Routine Control Of A Sterilization Process For Medical Devices;
- ISO/TS 17665-2:2009-01-15 Sterilization Of Health Care Products Moist Heat o - Part 2: Guidance On The Application Of ISO 17665-1;
- ISO 11737-1 Second Edition 2006-04-01 Sterilization Of Medical Devices - O Microbiological Methods - Part 1: Determination Of A Population Of Microorganisms On Products [Including: Technical Corrigendum 1 (2007)]; and
- ISO 11737-2 Second Edition 2009-11-15 Sterilization Of Medical Devices o Microbiological Methods - Part 2: Tests Of Sterility Performed In The Definition, Validation and Maintenance Of A Sterilization Process.
- biocompatibility; ●
- ISO 6474-1 First Edition 2010-02-15 Implants for Surgery Ceramic Materials o Part 1: Ceramic Materials Based on High Purity Alumina, and
- o ISO 6872 Fourth Edition 2015-06-01 Dentistry Ceramic Materials.
- bacterial endotoxin testing (LAL Method); ●
- analysis of surface composition; and
- surface roughness and contact angle testing.
Clinical Studies
Data supporting the Zeramex® T Dental Implant System and Zeramex® P6 Dental Implant System are applicable to the subject devices as the products are made from the same materials, undergo the same surface treatments, and have the same outer design. Fatigue testing supports that the subject devices can withstand clinically relevant forces.
VIII. Conclusion
Based on the above information, the Zeramex® XT and NobelPearl Implant Systems can be considered substantially equivalent to the identified predicate devices.
9
Although minor differences in design and technology exist between the subject and predicate devices, substantial equivalence has been demonstrated through a comparison of intended use, design, technological characteristics, and performance evaluations. Therefore, the Zeramex® XT and NobelPearl Dental Implant Systems are substantially equivalent to the predicate devices.